Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors

J Endocrinol Invest. 2003;26(8 Suppl):82-8.

Authors

R Pivonello¹, D Ferone, M Filippella, A Faggiano, M C De Martino, R S Auriemma, F Rota, G Lombardi, A Colao

Affiliation

¹ Department of Molecular and Clinical Endocrinology and Oncology, Federico II University, Naples, Italy. [email protected]

PMID: 15233220

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents, Hormonal / therapeutic use*
Gastrointestinal Neoplasms / diagnosis
Gastrointestinal Neoplasms / drug therapy*
Humans
Neuroendocrine Tumors / drug therapy*
Pancreatic Neoplasms / classification
Pancreatic Neoplasms / diagnosis
Pancreatic Neoplasms / drug therapy*
Pituitary Neoplasms / classification
Pituitary Neoplasms / diagnosis
Pituitary Neoplasms / drug therapy*
Pituitary Neoplasms / surgery
Somatostatin / analogs & derivatives*
Somatostatin / therapeutic use

Substances

Antineoplastic Agents, Hormonal
Somatostatin